R
Reuven Viskoper
Publications - 2
Citations - 171
Reuven Viskoper is an academic researcher. The author has contributed to research in topics: Type 2 diabetes & Valsartan. The author has an hindex of 2, co-authored 2 publications receiving 169 citations.
Papers
More filters
Journal ArticleDOI
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: The VALUE trial
Sverre E. Kjeldsen,Sverre E. Kjeldsen,Stevo Julius,Giuseppe Mancia,Gordon T. McInnes,Tsushung Hua,Michael A. Weber,Antonio Coca,Steffan Ekman,Xavier Girerd,Kenneth Jamerson,Pierre Larochelle,Thomas M. MacDonald,Roland E. Schmieder,M. Anthony Schork,Pelle Stolt,Reuven Viskoper,Jiri Widimský,Alberto Zanchetti +18 more
TL;DR: Treatment of hypertensive patients at high cardiovascular risk with the angiotensin-receptor blocker valsartan prevents new-onset type 2 diabetes compared with the metabolically neutral calcium-channel antagonist (CCA) amlodipine, and reduces the risk of developing diabetes mellitus in high-risk hypertensive Patients.
Journal ArticleDOI
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial
Sverre E. Kjeldsen,Gordon T. McInnes,Giuseppe Mancia,Tsushung A. Hua,Stevo Julius,Michael A. Weber,Antonio Coca,Xavier Girerd,Kenneth Jamerson,Pierre Larochelle,Thomas M. MacDonald,Roland E. Schmieder,M. Anthony Schork,Reuven Viskoper,Jiri Widimsky,Alberto Zanchetti +15 more
TL;DR: It is concluded that valsartan compared with amlodipine reduces the risk of developing diabetes mellitus, particularly in hypertensive patients with the highest susceptibility for development of diabetes.